Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1643, 2008-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Current and Future Treatment Directions in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Access to resources
Recommend
T2DM treatment targets scrutinised at ADA: nothing needs to change
Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. :
Variable results for targeted insulin treatment in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Pioglitazone improves measures of T2DM and dyslipidaemia
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Thiazolidinediones considered in T2DM management update
Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. :